Constantine Chinoporos
Chief Operating Officer at APPLIED THERAPEUTICS, INC.
Net worth: 2 M $ as of 2024-03-30
Constantine Chinoporos active positions
| Companies | Position | Start | End |
|---|---|---|---|
| APPLIED THERAPEUTICS, INC. | Chief Operating Officer | 2023-12-27 | - |
Career history of Constantine Chinoporos
Former positions of Constantine Chinoporos
| Companies | Position | Start | End |
|---|---|---|---|
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | 2021-12-01 | 2023-02-28 |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2015-10-31 | 2021-09-30 |
Training of Constantine Chinoporos
| Cornell University | Masters Business Admin |
Statistics
International
| United States | 5 |
Operational
| Corporate Officer/Principal | 2 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| APPLIED THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Commercial Services |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |